Transcode Therapeutics Secures Equity Investment from White Lion Capital for Advancing TTX-MC138 in Glioblastoma Treatment

marketinsights05 mins

Welcome to the Future of Cancer Treatment with TransCode Therapeutics Exciting News for TransCode Therapeutics BOSTON, April 14, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a Common Stock Purchase…

Read More

“Breaking Free: Tornado Cash Developer Alexey Pertsev Released from Dutch Prison, Appeals Five-Year Sentence”

marketinsights04 mins

The software developer behind Tornado Cash set to be conditionally released In a surprising turn of events, Alexey Pertsev, the software developer who found himself behind bars due to his involvement in the crypto mixing protocol Tornado Cash, will soon be walking free. According to a post on social media platform X, Pertsev announced that…

Read More

Context Therapeutics: Unveiling a Year of Progress – Full-Year 2024 Operating and Financial Results

financenews04 mins

Context Therapeutics: A Transformative Year in Review Context Therapeutics Inc., a clinical-stage biopharmaceutical company specializing in T cell engaging bispecific antibodies for solid tumors, reported its financial results for the year ended December 31, 2024. The company’s CEO, Martin Lehr, expressed his satisfaction with the progress made during the year. Strategic Acquisitions Throughout 2024, Context…

Read More

Join Us in September: Hookipa Pharma’s Exciting Participation in Upcoming Investor Conferences!

marketnews04 mins

Join Us in September: Hookipa Pharma’s Exciting Participation in Upcoming Investor Conferences! NEW YORK and VIENNA, Austria, Sept. 06, 2023 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that HOOKIPA’s management team will participate in and present at…

Read More

“Join the CLAS Craze: Deadline Looming on February 10, 2025 – Don’t Miss Out! Contact Levi and Korsinsky Today!”

marketinsider03 mins

Recovering From Investment Loss with Cassava Sciences, Inc. New York, NY / ACCESS Newswire / January 30, 2025 Have you recently suffered a loss on your Cassava Sciences, Inc. investment? If so, you may be wondering about potential ways to recover under the federal securities laws. The process of dealing with investment losses can be…

Read More

Akamai’s AI Advantage: Unveiling the Power of Akamai Cloud Inference

marketnews05 mins

Revolutionizing Business Operations with Akamai Cloud Inference: Akamai Technologies, a leading cybersecurity and cloud computing company, has recently introduced Akamai Cloud Inference, a groundbreaking service designed to help businesses unlock the full potential of predictive and large language models (LLMs). This service aims to deliver a remarkable 3x improvement in throughput, an impressive 60% reduction…

Read More